Global DNA Synthesis Market Size, Share, Trends & Growth Analysis Report 2026-2034

Description

The DNA Synthesis Market size is expected to reach USD 31.53 Billion in 2034 from USD 6.39 Billion (2025) growing at a CAGR of 19.41% during 2026-2034.

The Global DNA Synthesis Market is witnessing significant growth due to increasing applications in synthetic biology, gene therapy, vaccine development, and diagnostics. Advances in biotechnology and the rising demand for customized genetic sequences are driving the expansion of this market. Research institutions, pharmaceutical companies, and biotech firms are major contributors to its growing demand.

Important growth drivers include declining DNA synthesis costs, improvements in automation technologies, and strong investments in genetic research. The rapid development of gene and cell therapies has created a strong need for high-quality synthetic DNA. Additionally, government funding and private investments in life sciences research are further supporting market development globally.

Looking forward, the DNA synthesis market is expected to expand rapidly with innovations in enzymatic synthesis and high-throughput platforms. Faster turnaround times, improved accuracy, and enhanced biosecurity measures will strengthen industry growth. As biotechnology continues to evolve, DNA synthesis will remain a fundamental technology supporting the future of healthcare and industrial biology.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Service

Oligonucleotide Synthesis
Gene Synthesis

By Method

Solid-phase Synthesis
PCR-based Enzyme Synthesis
Chip-based Synthesis

By Application

Research and Development
Diagnostics
Therapeutics

By End-Use

Biopharmaceutical Companies
Academic & Research Institutes
Contract Research Organizations

COMPANIES PROFILED

Biomatik Corporation, Bioneer Corporation, Eton Bioscience Inc, Eurofins Scientific SE, GenScript Biotech Corporation, IBA Lifesciences GmbH, Integrated DNA Technologies Inc, Kaneka Eurogentec SA, LGC Biosearch Technologies, OriGene Technologies Inc, ProMab Biotechnologies Inc, ProteoGenix, Quintara Biosciences, Synbio Technologies, Thermo Fisher Scientific Inc
We can customise the report as per your requirements.

Product Code: VMR112110405

Chapter 1. PREFACE

1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

2.1. Market Snapshot
2.2. Segmental Outlook
2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

3.1. Market Lineage Outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Value Chain Analysis
3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
3.6. Porter's Five Forces Analysis
3.7. PESTLE Analysis

Chapter 4. GLOBAL DNA SYNTHESIS MARKET: BY SERVICE 2022-2034 (USD MN)

4.1. Market Analysis, Insights and Forecast Service
4.2. Oligonucleotide Synthesis Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.3. Gene Synthesis Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL DNA SYNTHESIS MARKET: BY METHOD 2022-2034 (USD MN)

5.1. Market Analysis, Insights and Forecast Method
5.2. Solid-phase Synthesis Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.3. PCR-based Enzyme Synthesis Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.4. Chip-based Synthesis Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL DNA SYNTHESIS MARKET: BY APPLICATION 2022-2034 (USD MN)

6.1. Market Analysis, Insights and Forecast Application
6.2. Research and Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.3. Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.4. Therapeutics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL DNA SYNTHESIS MARKET: BY END-USE 2022-2034 (USD MN)

7.1. Market Analysis, Insights and Forecast End-use
7.2. Biopharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.3. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.4. Contract Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL DNA SYNTHESIS MARKET: BY REGION 2022-2034(USD MN)

8.1. Regional Outlook
8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.2.1 By Service
- 8.2.2 By Method
- 8.2.3 By Application
- 8.2.4 By End-use
- 8.2.5 United States
- 8.2.6 Canada
- 8.2.7 Mexico
8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.3.1 By Service
- 8.3.2 By Method
- 8.3.3 By Application
- 8.3.4 By End-use
- 8.3.5 United Kingdom
- 8.3.6 France
- 8.3.7 Germany
- 8.3.8 Italy
- 8.3.9 Russia
- 8.3.10 Rest Of Europe
8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.4.1 By Service
- 8.4.2 By Method
- 8.4.3 By Application
- 8.4.4 By End-use
- 8.4.5 India
- 8.4.6 Japan
- 8.4.7 South Korea
- 8.4.8 Australia
- 8.4.9 South East Asia
- 8.4.10 Rest Of Asia Pacific
8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.5.1 By Service
- 8.5.2 By Method
- 8.5.3 By Application
- 8.5.4 By End-use
- 8.5.5 Brazil
- 8.5.6 Argentina
- 8.5.7 Peru
- 8.5.8 Chile
- 8.5.9 South East Asia
- 8.5.10 Rest of Latin America
8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.6.1 By Service
- 8.6.2 By Method
- 8.6.3 By Application
- 8.6.4 By End-use
- 8.6.5 Saudi Arabia
- 8.6.6 UAE
- 8.6.7 Israel
- 8.6.8 South Africa
- 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

9.1. Recent Developments
9.2. Company Categorization
9.3. Supply Chain & Channel Partners (based on availability)
9.4. Market Share & Positioning Analysis (based on availability)
9.5. Vendor Landscape (based on availability)
9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL DNA SYNTHESIS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Company Profiles
- 10.2.1 Biomatik Corporation
- 10.2.2 Bioneer Corporation
- 10.2.3 Eton Bioscience Inc
- 10.2.4 Eurofins Scientific SE
- 10.2.5 GenScript Biotech Corporation
- 10.2.6 IBA Lifesciences GmbH
- 10.2.7 Integrated DNA Technologies Inc
- 10.2.8 Kaneka Eurogentec S.A
- 10.2.9 LGC Biosearch Technologies
- 10.2.10 OriGene Technologies Inc
- 10.2.11 ProMab Biotechnologies Inc
- 10.2.12 ProteoGenix
- 10.2.13 Quintara Biosciences
- 10.2.14 Synbio Technologies
- 10.2.15 Thermo Fisher Scientific Inc